Wedbush Adds Reddit to Best Ideas List With $250 Target Ahead of Q2 Earnings
Strong Q2 ads & AI deals expected. DA Davidson Buy at $200. Results July 30.
Already have an account? Sign in.
Strong Q2 ads & AI deals expected. DA Davidson Buy at $200. Results July 30.
GSK will buy a Chimagen trispecific T-cell engager for multiple myeloma. Phase I trials start in 2027. The deal is worth up to $750 million.
Phase 2 ADDRESS-LC missed statistical significance overall. 21 of 22 measures favored bezisterim; benefits were strongest in severe-symptom subgroups.
The catalyst: an out-of-court deal that keeps exclusive rights to onvansertib. Cash remains tight.